We could not find any results for:
Make sure your spelling is correct or try broadening your search.
- Companies Expect to Close the Transaction on November 3, 2006 - CORONA, Calif. and FT. LAUDERDALE, Fla., Oct. 31 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI) today...
CORONA, Calif., Oct. 18 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI) today announced that it has certified to the Federal Trade Commission (FTC) that it believes it is in...
Andrx Corporation (Nasdaq:ADRX) ("Andrx" or the "Company") announced today that on September 12, 2006, it certified that each representation and warranty of the Company contained in the merger...
Andrx Corporation (Nasdaq:ADRX) ("Andrx" or the "Company") today announced its financial results for the three and six months ended June 30, 2006 (the "2006 Quarter" and "2006...
Andrx Corporation (NASDAQ:ADRX) today announced that it plans to issue its 2006 second quarter financial results press release and file its Form 10-Q on Tuesday, August 8, 2006, after the...
Andrx Corporation (Nasdaq:ADRX) ("Andrx" or the "Company") today announced its financial results for the three months ended March 31, 2006 (the "2006 Quarter"), which are discussed...
CORONA, Calif. and FORT LAUDERDALE, Fla., May 3 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI) and Andrx Corporation (NASDAQ:ADRX) today announced that they have each received...
Andrx Corporation (NASDAQ:ADRX) today announced that it plans to issue its 2006 first quarter financial results press release and file its Form 10-Q on Thursday, May 4, 2006, after the...
Andrx Corporation (Nasdaq:ADRX) announced today that Takeda Global Research & Development Center Inc. filed a New Drug Application (NDA) for a combination product consisting of Takeda's ACTOS(R...
Andrx Corporation (Nasdaq:ADRX) ("Andrx" or the "Company") today announced its financial results for the three months and year ended December 31, 2005 (the "2005 Quarter" and the "2005 Year...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions